Press Releases about PfizerExposures
COVID-19
From Pfizer Inc.
Via Business Wire
From Pfizer Inc.
Via Business Wire
Via MarketBeat
Topics
Artificial Intelligence
Via MarketBeat
Topics
Initial Public Offering
Pfizer’s Elranatamab Receives FDA and EMA Filing Acceptance
February 22, 2023
From Pfizer Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|